Skip to main content
. Author manuscript; available in PMC: 2014 Jan 2.
Published in final edited form as: J Pain Symptom Manage. 2010 May;39(5):10.1016/j.jpainsymman.2009.09.013. doi: 10.1016/j.jpainsymman.2009.09.013

Fig. 1.

Fig. 1

Proportion of men receiving LHRH agonists, orchiectomy, or no ADT, by diagnosis year for African-American and white men with metastatic prostate cancer, SEER-Medicare 1991–1999.